• Patent to combat Candidiasis with lama antibodies [VHH]

QVQ Holding b.v. and Hans Knoll Institute in Jena [Germany] have filed a patent to combat Candidiasis  with lama antibodies [VHH]. Candidiasis is caused by Candida albicans and infection with C. albicans can be life threatening when entering the blood stream. By filing this patent QVQ strengthens its leading position in the development of VHH to fight infectious diseases

[see our products against infectious diseases]